Form EFFECT Pelthos Therapeutics
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 9, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pelthos Therapeutics added to Russell Microcap indexes
- CaratIQ Announces Exclusive Partnership with Nationwide Jewellers to Bring AI-Powered Cloud POS Technology to Australia and New Zealand
- IMS Group to Appoint John M. Caccia as Chairman and Partner
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share